Increasing complexity: which drug class to choose for treatment of hypertension in the elderly?

Abstract

Treatment of hypertension in the elderly is expected to become more complex in the coming decades. Based on the current landscape of clinical trials, guideline recommendations remain inconclusive. The present review discusses the latest evidence derived from studies available in 2013 and investigates optimal blood pressure (BP) and preferred treatment substances. Three common archetypes are discussed that hamper the treatment of hypertension in the very elderly. In addition, this paper presents the current recommendations of the NICE 2011, JNC7 2013-update, ESH/ESC 2013, CHEP 2013, JNC8 and ASH/ISH guidelines for elderly patients. Advantages of the six main substance classes, namely diuretics, beta-blockers (BBs), calcium channel blockers (CCBs), angiotensin-converting enzyme inhibitors (ACEIs), angiotensin receptor blockers (ARBs), and direct renin inhibitors (DRIs) are discussed. Medical and economic implications of drug administration in the very elderly are presented. Avoidance of treatment-related adverse effects has become increasingly relevant. Current substance classes are equally effective, with similar effects on cardiovascular outcomes. Selection of substances should therefore also be based on collateral advantages of drugs that extend beyond BP reduction. The combination of ACEIs and diuretics appears to be favorable in managing systolic/diastolic hypertension. Diuretics are a preferred and cheap combination drug, and the combination with CCBs is recommended for patients with isolated systolic hypertension. ACEIs and CCBs are favorable for patients with dementia, while CCBs and ARBs imply substantial cost savings due to high adherence.

Epidemiology and Public Health Concerns of CKD in Older Adults

“…Similarly, guidelines are conflicting regarding the optimal blood pressure targets and choice of blood pressure-lowering agents for older patients with CKD. 37 Given the heterogeneity in patient characteristics and preferences, it is important to consider which outcomes matter most for individual patients when making decisions about therapy. For example, some patients may care most about maximizing longevity, whereas others may consider quality of life and daily functioning equally important.…”

High positive end expiratory pressure levels affect hemodynamics in elderly patients with hypertension admitted to the intensive care unit: a prospective cohort study

“…The number of elderly patients with essential hypertension is increasing annually at a rapid rate worldwide [1, 2]. Recent data from the National Health and Nutrition Examination Survey indicate that 70% of older adults have hypertension [3].…”

The Prescription of Vitamin K Antagonists in a Very Old Population: A Cross-Sectional Study of 8696 Ambulatory Subjects Aged Over 85 Years

“…Concerning concomitant cardiovascular medications, beta-blockers, angiotensin-conversion-enzyme inhibitors, angiotensin-receptor-blockers, nitrate derivatives, diuretics, cardiac glycosides, other antiarrhythmic drugs, and hypolipidemic drugs (including statins) were more commonly prescribed in VKAG than in noVKAG. This result can be explained by the fact that cardiovascular diseases were more frequent in the VKAG [ 7 , 29 , 30 , 31 ]. A study showed a risk of overdose for phenprocoumon and acenocoumarol in cases of concomitant statins use [ 32 ].…”